Allogenic Adipose-derived Mesenchymal Stem Cells (AMSCs)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogenic Adipose-derived Mesenchymal Stem Cells (AMSCs), covering 2025-04-24 to 2025-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery [EARLY_Phase 1]